Adenosine A3 receptor and brain. A culprit, a hero, or merely yet another receptor?

Annals of the New York Academy of Sciences

Volumn 825, Issue , 1997, Pages 49-69

  Von Lubitz, Dag K J E ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,9 DIHYDRO 6 METHOXYCARBONYL 9 METHYL 2 PHENYL 1,2,4 TRIAZOLO[5,1 A][2,7]NAPHTHYRIDINE; ADENOSINE; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR STIMULATING AGENT; BRAIN RECEPTOR; L 268605; MRS 1067; MRS 1097; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR; DRUG DERIVATIVE;

BRAIN; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CONFERENCE PAPER; DRUG STRUCTURE; GENETIC TRANSDUCTION; GERBIL; MOLECULAR CLONING; NONHUMAN; PROTEIN STRUCTURE; RECEPTOR AFFINITY; SECOND MESSENGER; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN SECONDARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

GERBILLINAE;

ADENOSINE; AMINO ACID SEQUENCE; ANIMALS; BRAIN; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 0030613749     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48413.x     Document Type: Conference Paper

References (59)

1. MYERHOF, W. R., R. MÜLLER-BRECHLIN & D. RICHTER. 1991. Molecular cloning of a novel putative G protein-coupled receptor expressed during rat spermiogenesis. FEBS Lett. 284: 155-160.
2. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA 89: 7432-7436.
3. 3 adenosine receptor with widespread tissue distribution. Mol. Pharmacol. 44: 524-532.
4. 3 adenosine receptor. Proc. Natl. Acad. Sci. USA 90: 10365-10369.
5. 3 receptors: design of selective ligands and therapeutic prospects. Drugs Future 20:689-699.
6. VAN RHEE, A. M. & K. A. JACOBSON. 1996. Molecular architecture of G protein-coupled receptor. Drug Dev. Res. 37: 1-38.
7. 3 receptor. Mol. Pharmacol. 45:1101-1111.
8. 1 adenosine receptor mediates specific agonist binding. J. Biol. Chem. 269: 2373-2376.
9. 3 adenosine receptors. Drug Dev. Res. 33: 51-59.
10. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 15: 298-306.
11. 3 adenosine receptor. J. Biol. Chem. 28: 16895-16902.
12. VAN CALKER, D., M. MÜLLER & G. HAMPRECHT. 1979. Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 56: 999-1005.
13. 3 AR is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268: 16887-16890.
14. 3 receptors in rat brain. Mol. Pharmacol. 48: 1038-1045.
15. 3 receptor agonists on astrocytes: induction of cell protection at low and cell death at high concentrations. Drug Dev. Res. 3: 177.
16. VON LUBITZ, D. K. J. E., M. F. CARTER, M. BEENHAKKER, R. C.-S. LIN & K. A. JACOBSON. 1995. Adenosine: a prototherapeutic concept in neurodegeneration. In Neuroprotective Agents: Clinical and Experimental Aspects. B. Trembly & W. Slikker, Jr., Eds. Ann. N. Y. Acad. Sci. 765: 163-178.
17. 1 adenosine receptors. FEBS Lett. 209: 122-128.
18. 1 receptors in mammalian brain: species differences in their interactions with agonists and antagonists. Drug. Dev. Res. 9: 85-93.
19. 3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br. J. Pharmacol. 109: 3-5.
20. 3 selective adenosine agonists. J. Med. Chem. 37: 636-646.
21. 3 adenosine receptors. J. Med. Chem. 21: 3614-3621.
22. SIDDIQI, S. M., K. A. JACOBSON, J. L. ESKER, M. E. OLAH, X.-D. JI, N. MELMAN, K. N. TIWARI, J. A. SECRIST III, S. W. SCHNELLER, G. CRISTALLI, G. L. STILES, C. R. JOHNSON & I. P. IJZERMAN. 1995. Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors. J. Med. Chem. 7: 1174-1188.
23. 3 adenosine receptors. J. Med. Chem. 10: 1711-1719.
24. 3 adenosine receptors. Mol. Pharmacol. 45: 978-982.
25. JI, X.-D., N. MELMAN & K. A. JACOBSON. 1995. Interactions of flavonoids and other phytochemicals with adenosine receptors. J. Med. Chem. 3: 781-788.
26. 3 adenosine receptor antagonists. Drug Dev. Res. 3: 131.
27. 3 adenosine receptor antagonists. Drug Dev. Res. 3: 131.
28. 3 receptors potentiate hippocampal Ca current by a PKA-dependent/PKC-independent pathway. Drug Dev. Res. 3: 121.
29. SCHUBERT, P., U. HEINEMAN & R. KOLB. 1986. Differential effects of adenosine on pre-and postsynaptic calcium fluxes. Brain Res. 376: 382-386.
30. 3 receptor agonist-induced neurotoxicity in rat cerebellar granule neurons. Drug Dev. Res. In press.
31. 2+ mobilization in conjunction with metabotropic glutamate receptor activation by t-ACPD in cultures hippocampal astrocytes. Neurosci. Lett. 170: 5-10.
32. 2a receptor expression intrastriatal neurons: implications for basal ganglia physiology. Drug Dev. Res. 28: 381-385.
33. 3 receptor agonists on mammalian astrocytes: protection at lost and apoptosis at high concentrations. J. Neurosci. In press.
34. 3 receptors regulate serotonin transport via nitric oxide and cGMP. J. Biol. Chem. 44: 27351-27356.
35. MONOGUE, K. R., S. J. H. VAN DEVENTER & A. CERAMI. 1992. Tumor necrosis factor alpha or cachectin. In The Cytokine Handbook. A. Thomson, Ed. 241-256. Academic Press. San Diego.
36. BOUMA, M. G., R. K. STAD, F. A. J. M. VAN DEN WILDENBERG & W. A. BUURMAN. 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153: 4159-4168.
37. 3 adenosine receptors. J. Immunol. 156: 3435-3442.
38. PERRY, V. H. 1994. Macrophages and the Nervous System. 1-123. R. G. Landes. Molecular Biology Intelligence Unit. Austin.
39. + and glutamate-evoked release of endogenous adenosine from rat cortical slices. J. Neurochem. 54: 256-265.
40. MANZONI, O. J., T. MANABE & R. A. NICOLL. 1994. Release of adenosine by activation of NMDA receptors in the hippocampus. Science 265: 2098-2101.
41. 3-adenosine receptors: mediation of behavioral depressant effects. FEBS Lett. 1: 57-60.
42. 3 receptors and ischemic brain injury: a hope or a disaster? Drug Dev. Res. 3: 140.
43. KOTLYAR, B. I. & A. S. PIVOVAROV. 1990. Molecular mechanisms of neuronal plasticity during learning: the role of secondary messengers. Neurosci. Behav. Physiol. 2: 118-135.
44. MCENTEE, W. J. & T. H. CROOK. 1991. Serotonin, memory, and the aging brain. Psychopharmacology 103: 143-149.
45. HAGBERG, H., P. ANDERSSON, J. LAZAREWICZ, I. JACOBSON, S. BUTCHER & M. SANDBERG. 1987. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J. Neurochem. 49: 227-231.
46. 3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 263: 59-67.
47. 3 receptor stimulation on seizures in mice. Eur. J. Pharmacol. 275: 23-29.
48. KUDO, T., K. TADA, M. TAKEDA & T. NISHIMURA. 1990. Learning impairment and microtubule-associated protein 2 decrease in gerbils under chronic cerebral hypoperfusion. Stroke 21: 1205-1209.
49. DAWSON, T. M. & S. H. SNYDER. 1994. Gases as biological messengers: nitric oxide and carbon monoxide in the brain: J. Neurosci. 9: 5147-5159.
50. LIPTON, S. A. & J. S. STAMLER. 1994. Actions of redox-related congeners of nitric oxide at the NMDA receptor. Neuropharmacology 11: 1229-1233.
51. IADECOLA, C., D. A. PELLEGRINO, M. A. MOSKOWITZ & N. LASSEN. 1995. Nitric oxide synthase inhibition and cerebrovascular regulation. J. Cereb. Blood Flow Metab. 14: 175-192.
52. AOKI, E., I. K. TAKEUCHI & R. SHOJI. 1995. Nitric oxide: an attractive signalling molecule. Acta Histochem. Cytochem. 2: 97-106.
53. 3 receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 23: 16887-16890.
54. 3 receptor-mediated hypotension in the rat. Br. J. Pharmacol. 115:945-957.
55. 3 receptor activation in rats. Eur. J. Pharmacol. 298: 293-297.
56. DOYLE, M. P., J. LINDEN & B. R. DULING. 1994. Nucleoside-induced arteriolar constriction: a mast cell-dependent response. Am. J. Physiol. 266(Heart Circ. Physiol. 35): H2042-H2050.
57. 3 receptor agonists. Biochem. Biophys. Res. Commun. 219: 904-910.
58. RUDOLPHI, K. A. & P. SCHUBERT. 1996. Purinergic interventions in traumatic and ischemic injury. In Novel Therapies for CNS Injuries: Rationales and Results: P. L. Peterson & S. W. Phillis, Eds., 327-346. CRC Press. Boca Raton.
59. MARANGOS, P. J., D. K. J. E. VON LUBITZ, J.-L. DAVAL & J. DECKERT. 1990. Adenosine: its relevance to the treatment of brain ischemia and trauma. Current and Future Trends in Anticonvulsant, Anxiety, and Stroke Therapy. B. S. Meldrum and M. Williams, Eds. 331-349. Wiley-Liss, Inc. Baltimore.